Abbott Laboratories’ one-year average price target was cut 10.05% to €102.05 per share from €113.46 on April 14, 2026. The update reflects a weaker analyst valuation outlook, but the article provides no new operating or earnings data. Impact is likely limited to sentiment around the stock rather than the broader market.
Abbott Laboratories’ one-year average price target was cut 10.05% to €102.05 per share from €113.46 on April 14, 2026. The update reflects a weaker analyst valuation outlook, but the article provides no new operating or earnings data. Impact is likely limited to sentiment around the stock rather than the broader market.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
